20 Mar 2018 07:00
PUBLICATION OF NOTICE OF GENERAL MEETING
London, 20 March 2018 - Mereo BioPharma Group plc (AIM: MPH) (the "Company"), a multi-asset biopharmaceutical company focused on rare and specialty diseases, confirms that an explanatory circular (the "Circular"), which incorporates a notice convening a general meeting (the "Notice of General Meeting"), and a form of proxy will be posted to shareholders today.
The general meeting is to be held at the offices of Latham & Watkins (London) LLP, 99 Bishopsgate, London EC2M 3XF at 12.00 pm (noon) (London time) on 6 April 2018 and is being held in order for shareholders to vote on the adoption of new articles of association of the Company (the "New Articles").
A copy of the Circular (incorporating the Notice of General Meeting) is available on the Company's website at www.mereobiopharma.com/investors-page/regulatory-news/.
The New Articles and the current articles of association (and a comparison of changes to the current articles of association) are also available for inspection on the Company's website at www.mereobiopharma.com/investors-page/aim-rule-26/.
FOR FURTHER ENQUIRIES:
Mereo BioPharma Group plc
+44 (0)333 023 7319
Denise Scots-Knight, Chief Executive Officer
Richard Jones, Chief Financial Officer
Nominated Adviser and Joint Broker
CantorFitzgerald Europe
+44 (0)20 7894 7000
Phil Davies
Will Goode
Joint Broker
RBC Capital Markets
+44 (0)20 7653 4000
Rupert Walford
Laura White
Public Relations Adviser to Mereo Biopharma
FTI Consulting
+44 (0)20 3727 1000
Ben Atwell
Simon Conway
Brett Pollard